AGP Picks
View all

Clinical microbiology market seen growing 8.5% annually to 2030

an hour ago
Clinical microbiology market seen growing 8.5% annually to 2030
By AI, Created 00:30 UTC, Nov 19, 2026, AGP -

The global clinical microbiology market is projected to rise from $7.38 billion in 2025 to $11.08 billion by 2030, driven by infectious disease testing demand, lab automation and rapid diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Clinical microbiology sits at the center of infectious disease detection and treatment decisions. - Faster growth in the market points to stronger demand for diagnostic tools, lab automation and antimicrobial resistance testing. - The market outlook suggests more spending on hospital and clinical laboratory capabilities across major regions.

What happened: - The clinical microbiology market is projected to grow from $7.38 billion in 2025 to $8.01 billion in 2026. - The market is forecast to reach $11.08 billion by 2030, at a CAGR of 8.5%. - The Business Research Company published the outlook on Nov. 19, 2026. - The company also made a free sample of the market report available. - The full clinical microbiology market report is also available.

The details: - Market growth over the historical period was driven by rising infectious disease cases. - Expansion of hospital-based diagnostic infrastructure supported demand. - Clinical laboratories are handling higher testing volumes. - Demand for precise pathogen identification is increasing. - Laboratory automation technologies are improving workflow efficiency. - Future growth is expected to come from wider adoption of rapid diagnostic platforms. - Investment in sophisticated clinical laboratories is also expected to rise. - Demand for antimicrobial resistance testing is increasing. - Molecular microbiology techniques are broadening in use. - AI-assisted diagnostic tools are being added to routine microbiology workflows. - Emerging trends include automated microbiology analyzers, expanded molecular diagnostics, mass spectrometry integration for pathogen identification, rapid microbial testing solutions and enhanced laboratory workflow automation. - Clinical microbiology is a medical science field focused on testing methods that isolate and identify microorganisms. - These diagnostic processes support patient care and treatment decisions. - Public and private funding is helping support advanced diagnostic tools, laboratory capabilities and public health responses. - In September 2024, Civil Society Media Limited reported that Cancer Research UK raised $0.0001737 billion in 2023-2024, up $0.0305 billion from $0.136 billion the prior year.

Between the lines: - The forecast reflects a market shift from conventional microbiology toward faster, more automated and more data-driven diagnostics. - Asia-Pacific is expected to outpace other regions as adoption and lab investment expand. - North America held the largest market share in 2025, showing that the market remains anchored in established healthcare systems even as growth accelerates elsewhere. - The report’s new additions, including TAM analysis, company scoring matrices and forecasting dashboards, point to more investor-focused market intelligence.

What's next: - Market growth is expected to continue through 2030 if hospitals and labs keep investing in automation and molecular testing. - The Asia-Pacific region is expected to be the fastest-growing regional market in the next several years. - Broader use of AI-assisted tools and rapid diagnostics will likely shape the next phase of competition in clinical microbiology.

The bottom line: - Clinical microbiology is moving toward faster, more automated and more precise diagnostics, with the market set to nearly double from 2025 to 2030.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Business Post Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Business Post Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.